Pregnancy
category ? CAS Number 132367-76-1 Molar mass 259.087 g/mol | ATC code none PubChem CID 131506 | |
 | ||
Routes of
administration Oral, Insufflated, Rectal Legal status In general: uncontrolled | ||
5-Iodo-2-aminoindane (5-IAI) is a drug which acts as a releasing agent of serotonin, norepinephrine, and dopamine. It was developed in the 1990s by a team led by David E. Nichols at Purdue University. 5-IAI fully substitutes for MDMA in rodents and is a putative entactogen in humans. Unlike related aminoindane derivatives like MDAI and MMAI, 5-IAI causes some serotonergic neurotoxicity in rats, but is substantially less toxic than its corresponding amphetamine homologue pIA, with the damage observed barely reaching statistical significance.
References
5-IAI Wikipedia(Text) CC BY-SA